Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Syndax Pharmaceuticals (SNDX) Return on Capital Employed (2016 - 2020)

Syndax Pharmaceuticals has reported Return on Capital Employed over the past 5 years, most recently at 0.32% for Q4 2020.

  • Quarterly results put Return on Capital Employed at 0.32% for Q4 2020, up 79.0% from a year ago — trailing twelve months through Dec 2020 was 0.32% (up 79.0% YoY), and the annual figure for FY2025 was 0.54%, up 6.0%.
  • Return on Capital Employed for Q4 2020 was 0.32% at Syndax Pharmaceuticals, up from 0.39% in the prior quarter.
  • Over the last five years, Return on Capital Employed for SNDX hit a ceiling of 0.22% in Q2 2016 and a floor of 1.12% in Q4 2019.
  • Median Return on Capital Employed over the past 5 years was 0.53% (2017), compared with a mean of 0.63%.
  • Biggest five-year swings in Return on Capital Employed: plummeted -49bps in 2018 and later soared 79bps in 2020.
  • Syndax Pharmaceuticals' Return on Capital Employed stood at 0.42% in 2016, then fell by -27bps to 0.54% in 2017, then plummeted by -90bps to 1.02% in 2018, then decreased by -9bps to 1.12% in 2019, then surged by 71bps to 0.32% in 2020.
  • The last three reported values for Return on Capital Employed were 0.32% (Q4 2020), 0.39% (Q3 2020), and 0.43% (Q2 2020) per Business Quant data.